Interleukin-13 Assessment in Gingival Crevicular Fluid of Patients with Periodontal Disease
Downloads
The present study holds significant potential to assess interleukin 13 (IL-13) levels in Crevicular Gingival Fluid (CGF) as a potential immunological marker for bone remodeling in subjects with periodontal disease. Thirty-nine subjects were included, with 19 diagnosed with gingivitis and 20 with periodontitis. The latter were classified following the new classification of periodontal and peri-implant diseases in stages I (6%), II (6%), III (6%), and IV (2%). Crevicular gingival fluid was meticulously collected with filter paper strips. Volume quantification was obtained with Periotron 8000® and analyzed by ELISA, ensuring the accuracy of our results. Diagnosed gingivitis patients showed a mean IL-13 level in CGF of 4.42 ± 7.5 pg/μl; in contrast, patients diagnosed in stage II of periodontitis showed higher (44.3 ± 7.5 pg/μl), followed by patients in stage III (27.5 ± 4.3 pg/μl), stage IV (25.4 ± 10.9 pg/μl) and stage I (13.8 ± 9.3 pg/μl). Due to its role in periodontitis, IL-13 might be a possible immunological marker to differentiate between bone remodeling between gingivitis and periodontitis. IL-13 might be an immunological marker playing a relevant bone role in periodontitis.
Bartold PM, Van Dyke TE. Host modulation: controlling the inflammation to control the infection. Periodontol 2000. 2017;75:317-29. https://doi.org/10.1111/prd.12169.
Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Periodontol. 2018;89:S159-S72.
https://doi.org/10.1002/jper.18-0006.
Van Dyke TE, Sima C. Understanding resolution of inflammation in periodontal diseases: Is chronic inflammatory periodontitis a failure to resolve? Periodontol 2000. 2020;82:205-13.
https://doi.org/10.1111/prd.12317.
SIVEPAB. Resultados del sistema de vigilancia epidemiológica de patologías bucales, https://www.gob.mx/cms/uploads/attachment/file/525756/20200116_archivo_SIVEPAB-18_1nov19_1_.pdf; 2018 [accessed May 2020].
SIVEPAB. Resultados del Sistema de Vigilancia Epidemiológica de Patologías Bucales México 2015, https://www.gob.mx/cms/uploads/attachment/file/212323/SIVEPAB-2015.pdf; 2015 [accessed July
.
Chen D, Zhang TL, Wang X. Association between Polymorphisms in Interleukins 4 and 13 Genes and Chronic Periodontitis in a Han Chinese Population. Biomed Res Int. 2016;2016:8389020.
https://doi.org/10.1155/2016/8389020.
Macín-Cabrera S, Sanz-Alonso M, Castrillón-Rivera L, Palma-Ramos A, Noguez-Méndez N, Quirino-Barreda C, et al. Tratamiento periodontal no quirúrgico en pacientes con gingivitis y periodontitis moderada. Respuesta bioquímica y microbiológica. Revista Odontológica Mexicana. 2015;19:155-64.
https://doi.org/10.1016/j.rodmex.2015.07.002.
Fuschiotti P. Role of IL-13 in systemic sclerosis. Cytokine. 2011;56:544-9.
https://doi.org/10.1016/j.cyto.2011.08.030.
Wu Y, Chuang H, Ho Y, Ho K, Tsai C. Investigation of interleukin-13 gene polymorphisms in individuals with chronic and generalized aggressive periodontitis in a Taiwanese (Chinese) population. J Periodontal Res. 2010;45:695-701.
https://doi.org/10.1111/j.1600-0765.2010.01287.x.
Wynn TA. IL-13 Effector Functions. Annu Rev Immunol. 2003;21:425-56.
https://doi.org/10.1146/annurev.immunol.21.120601.141142.
Maruyama M, Rhee C, Utsunomiya T, Zhang N, Ueno M, Yao Z, et al. Modulation of the Inflammatory Response and Bone Healing. Front Endocrinol (Lausanne). 2020;11:386.
https://doi.org/10.3389/fendo.2020.00386.
AlQranei MS, Chellaiah MA. Osteoclastogenesis in periodontal diseases: Possible mediators and mechanisms. J Oral Biosci. 2020;62:123-30. https://doi.org/10.1016/j.job.2020.02.002.
Amarasekara DS, Yun H, Kim S, Lee N, Kim H, Rho J. Regulation of Osteoclast Differentiation by Cytokine Networks. Immune Netw. 2018;18:e8. https://doi.org/10.4110/in.2018.18.e8.
Metzger CE, Narayanan SA. The Role of Osteocytes in Inflammatory Bone Loss. Front Endocrinol. 2019;10:285.
https://doi.org/10.3389/fendo.2019.00285.
Chapple ILC, Mealey BL, Van Dyke TE, Bartold PM, Dommisch H, Eickholz P, et al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol.
;89:S74-S84. https://doi.org/10.1002/JPER.170719.
Lang NP, Bartold PM. Periodontal health. J Periodontol. 2018;89:S9-S16. https://doi.org/10.1002/JPER.16-0517.
Trombelli L, Farina R, Silva CO, Tatakis DN. Plaque-induced gingivitis: Case definition and diagnostic considerations. J Clin Periodontol. 2018;45:S44-S67. https://doi.org/10.1111/jcpe.12939.
Hajishengallis G, Korostoff JM. Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later. Periodontol 2000. 2017;75:116-51.
https://doi.org/10.1111/prd.12181.
Al-Hamoudi N, Alsahhaf A, Al Deeb M, Alrabiah M, Vohra F, Abduljabbar T. Effect of scaling and root planing on the expression of anti-inflammatory cytokines (IL-4, IL-9, IL-10, and IL-13) in the gingival crevicular fluid of electronic cigarette users and non-smokers with moderate chronic periodontitis. J Periodontal Implant Sci. 2020;50:74-82. https://doi.org/10.5051/jpis.2020.50.2.74.
Ghallab NA. Diagnostic potential and future directions of biomarkers in gingival crevicular fluid and saliva of periodontal diseases: Review of the current evidence. Arch Oral Biol. 2018;87:115-24. https://doi.org/10.1016/j.archoralbio.2017.12.022.
Beklen A. Effects of IL-13 on TGF-β and MMP-1 in periodontitis. Biotech Histochem. 2017;92:374-80. https://doi.org/10.1080/10520295.2017.1312526.
Gonzales JR, Gröger S, Haley G, Bödeker R-H, Meyle J. Production of Interleukin-13 is Influenced by the Interleukin-4 −34TT and −590TT Genotype in Patients with Aggressive Periodontitis. Scand J Immunol. 2011;73:128-34.
Copyright (c) 2025 Viridiana Altamirano Paredes, Susana Aurora Macín Cabrera, Laura Estela Castrillón Rivera, Jorge Ismael Castañeda Sánchez, José de Jesús Juárez Sandoval
This work is licensed under a Creative Commons Attribution 4.0 International License.
All Content should be original and unpublished.
